In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Outset Medical Inc (NASDAQ: OM) closed the day trading at $0.66 down -19.04% from the previous closing price of $0.82. In other words, the price has decreased by -$19.04 from its previous closing price. On the day, 4.5 million shares were traded. OM stock price reached its highest trading level at $0.8485 during the session, while it also had its lowest trading level at $0.66.
Ratios:
For a better understanding of OM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.38 and its Current Ratio is at 6.80. In the meantime, Its Debt-to-Equity ratio is 2.95 whereas as Long-Term Debt/Eq ratio is at 2.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’24 when Trigg Leslie sold 5,308 shares for $0.84 per share. The transaction valued at 4,459 led to the insider holds 910,496 shares of the business.
Nash Marc sold 1,293 shares of OM for $1,086 on Aug 15 ’24. The SVP Operations and R&D now owns 239,397 shares after completing the transaction at $0.84 per share. On Aug 15 ’24, another insider, Brottem John L., who serves as the General Counsel of the company, sold 3,011 shares for $0.84 each. As a result, the insider received 2,529 and left with 230,295 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 34587624 and an Enterprise Value of 42042624. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at 0.361 whereas that against EBITDA is -0.291.
Stock Price History:
Over the past 52 weeks, OM has reached a high of $15.55, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -81.43%, while the 200-Day Moving Average is calculated to be -82.02%.
Shares Statistics:
Over the past 3-months, OM traded about 1.56M shares per day on average, while over the past 10 days, OM traded about 5365280 shares per day. A total of 50.32M shares are outstanding, with a floating share count of 47.74M. Insiders hold about 8.36% of the company’s shares, while institutions hold 91.28% stake in the company. Shares short for OM as of 1722384000 were 7104830 with a Short Ratio of 4.55, compared to 1719532800 on 8561693. Therefore, it implies a Short% of Shares Outstanding of 7104830 and a Short% of Float of 15.97.
